31 – 45 of 47
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.
(
- Contribution to journal › Article
-
Mark
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.
(
- Contribution to journal › Article
-
Mark
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice
(
- Contribution to journal › Article
-
Mark
SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas.
(
- Contribution to journal › Article
- 2010
-
Mark
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
(
- Contribution to journal › Article
-
Mark
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays
(
- Contribution to journal › Article
-
Mark
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
International network of cancer genome projects
(
- Contribution to journal › Article
- 2009
-
Mark
The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer
(
- Contribution to journal › Article
-
Mark
Prognostic Significance of Stromal Platelet-Derived Growth Factor beta-Receptor Expression in Human Breast Cancer
(
- Contribution to journal › Article
-
Mark
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
2009) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 22. p.1564-1574(
- Contribution to journal › Article
- 2008
-
Mark
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
(
- Contribution to journal › Article